Patents by Inventor Jeffrey W. Seale

Jeffrey W. Seale has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150337294
    Abstract: Methods and compositions are provided for binding a target molecule comprising expressing a recombinant binding protein, such as an anticalin, an OB-domain protein, or an alpha-helix coiled-coil forming polypeptide in a plant. Methods for producing such a recombinant binding protein that binds to a target molecule are also provided. Further provided are plant lipocalin, OB-domain, and alpha-helix coiled-coil forming polypeptide coding sequences and recombinant polypeptides derived therefrom.
    Type: Application
    Filed: May 3, 2012
    Publication date: November 26, 2015
    Inventors: Paul Skatrud, Gerrit Segers, Sonya Franklin, Renata Bolognesi, James Roberts, Robert M. McCarroll, Bradon J. Fabbri, Jeffrey W. Seale
  • Patent number: 8067542
    Abstract: The present invention relates to an antifungal protein, AlfAFP1, which is a modified form of an antifungal protein isolated from Medicago plants, the modified form exhibiting enhanced anti-fungal activity for controlling fungal pathogenesis in plants. A method for inhibiting fungal colonization of plants is described which includes preparation of nucleotide sequences encoding the modified antifungal protein, preparation of vectors containing the nucleotide coding sequence, and methods for transforming plants with the nucleotide sequences. The polypeptide can be formulated into compositions useful in controlling plant pathogenic fungi.
    Type: Grant
    Filed: March 22, 2010
    Date of Patent: November 29, 2011
    Assignee: Monsanto Technology LLC
    Inventors: Jeffrey W Seale, Paul B. Vordtriede
  • Patent number: 7728190
    Abstract: The present invention relates to an antifungal protein, AlfAFP1, which is a modified form of an antifungal protein isolated from Medicago plants, the modified form exhibiting enhanced anti-fungal activity for controlling fungal pathogenesis in plants. A method for inhibiting fungal colonization of plants is described which includes preparation of nucleotide sequences encoding the modified antifungal protein, preparation of vectors containing the nucleotide coding sequence, and methods for transforming plants with the nucleotide sequences. The polypeptide can be formulated into compositions useful in controlling plant pathogenic fungi.
    Type: Grant
    Filed: November 17, 2003
    Date of Patent: June 1, 2010
    Assignee: Monsanto Technology LLC
    Inventors: Jeffrey W. Seale, Paul B. Vordtriede
  • Patent number: 7332596
    Abstract: A novel protein was isolated from Fusarium culmorum and characterized. The protein, termed FCWP1, demonstrated significant antifungal activity against several fungal species. Mutations in proteolytic consensus sequences contained within FCWP1 improved the stability of its antifungal activity. In addition, a class of proteins related to FCWP1 was identified and characterized. This class is made up of ribosomal proteins and displayed similar values for pI and molecular weight. A representative number of proteins from this class were tested and found to have significant antifungal activities. The antifungal proteins disclosed herein are useful in controlling fungal infections in plants. Transgenic plants may be produced that are more resistant to fungal infections relative to non-transgenic plants of the same species. Alternatively, the proteins may be applied to plants exogenously.
    Type: Grant
    Filed: April 23, 2003
    Date of Patent: February 19, 2008
    Assignee: Monsanto Technology LLC
    Inventors: Greg J. Bunkers, Jihong Liang, Cindy A. Mittanck, Jeffrey W. Seale, Yonnie S. Wu
  • Patent number: 6573361
    Abstract: A novel protein was isolated from Fusarium culmorum and characterized. The protein, termed FCWP1, demonstrated significant antifungal activity against several fungal species. Mutations in proteolytic consensus sequences contained within FCWP1 improved the stability of its antifungal activity. In addition, a class of proteins related to FCWP1 was identified and characterized. This class is made up of ribosomal proteins and displayed similar values for pI and molecular weight. A representative number of proteins from this class were tested and found to have significant antifungal activities. The antifungal proteins disclosed herein are useful in controlling fungal infections in plants. Transgenic plants may be produced that are more resistant to fungal infections relative to non-transgenic plants of the same species. Alternatively, the proteins may be applied to plants exogenously.
    Type: Grant
    Filed: December 7, 2000
    Date of Patent: June 3, 2003
    Assignee: Monsanto Technology LLC
    Inventors: Greg J. Bunkers, Jihong Liang, Cindy A. Mittanck, Jeffrey W. Seale, Yonnie S. Wu